Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · IEX Real-Time Price · USD

1.500

+0.180 (13.64%)

At close: Apr 24, 2024, 4:00 PM

1.540

+0.040 (2.67%)

After-hours: Apr 24, 2024, 7:55 PM EDT

Enlivex Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-29.07	-31.06	-14.47	-11.82	-9.38	-4.24	-2.5	-2.88	-15.37	-7.02	Upgrade
Depreciation & Amortization	0.84	0.78	0.55	0.29	0.37	0.12	0.08	0.06	0.02	0.01	Upgrade
Share-Based Compensation	1.95	2.71	2.91	0.67	0.81	1.01	0.12	0.11	2.62	0.74	Upgrade
Other Operating Activities	2.76	3.62	-6.53	-0.14	1.16	-0.05	-0	0.52	-0.52	1.87	Upgrade
Operating Cash Flow	-23.52	-23.95	-17.54	-11.01	-7.04	-3.16	-2.3	-2.19	-13.25	-4.41	Upgrade
Capital Expenditures	-0.1	-8.12	-1.63	-1.02	-0.19	-0.46	-0.13	-0.18	-0.05	-0.06	Upgrade
Acquisitions	-	0	0	0	1.54	0	0	0	0	0	Upgrade
Change in Investments	-25.87	70.65	-36.78	-19.96	-7.71	-0.04	0	5.01	10	-22	Upgrade
Investing Cash Flow	-25.97	62.52	-38.41	-20.98	-6.36	-0.5	-0.13	4.82	9.95	-22.06	Upgrade
Share Issuance / Repurchase	0.36	0.15	60.98	33.08	8.31	5.19	8.06	0.03	0	36.79	Upgrade
Financing Cash Flow	0.36	0.15	60.98	33.08	8.31	5.19	8.06	0.03	0	36.79	Upgrade
Exchange Rate Effect	0	0	-0.41	0.39	0.83	-0.77	0.37	0.1	0	0	Upgrade
Net Cash Flow	-49.13	38.72	5.03	1.1	-5.09	1.53	5.62	2.66	-3.3	10.31	Upgrade
Free Cash Flow	-23.63	-32.08	-19.17	-12.03	-7.23	-3.62	-2.43	-2.37	-13.3	-4.47	Upgrade
Free Cash Flow Per Share	-1.27	-1.74	-1.07	-0.91	-0.84	-1.03	-0.71	-0.71	-37.38	-14.59	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).